In Ewing sarcoma, IGF1R was early identified as a possible target for the treatment, of which the preclinical results were published, where Scotlandi et al. showed the proliferative effect of IGF1 on Ewing sarcoma cell lines [30]. This evidence concerns the gene IGF1R and Ewing sarcoma.